Oramed Pharmaceuticals Inc. (ORMP)

NASDAQ: ORMP · Real-Time Price · USD

3.490

-0.120 (-3.32%)

At close: Mar 20, 2026, 4:00 PM EDT

3.550

+0.060 (1.72%)

After-hours: Mar 20, 2026, 5:37 PM EDT

Oramed Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY	FY
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Aug '21 Aug 31, 2021	Aug '20 Aug 31, 2020
Cash & Equivalents	52.18	54.42	9.06	40.46	77.25	19.3
Short-Term Investments	82.51	87.51	152.99	115.26	16.9	20.6
Cash & Short-Term Investments	134.69	141.93	162.05	155.72	94.14	39.9
Cash Growth	-5.35%	-12.41%	4.06%	65.41%	135.94%	23.60%
Other Current Assets	1.43	1.29	0.54	1.39	1.2	0.61
Total Current Assets	136.12	143.22	162.58	157.11	95.34	40.51
Net Property, Plant & Equipment	1.43	1.11	1.57	1.8	0.93	0.17
Long-Term Investments	82.9	10.91	56.37	2.7	6.69	3.93
Other Long-Term Assets	0.04	0.03	0.03	0.03	25.04	0.02
Total Assets	220.49	155.28	220.55	161.64	128	44.63
Accounts Payable	4.86	5.14	1.61	4.16	3.79	1.7
Short-Term Debt	-	-	51.01	-	-	-
Current Portion of Leases	0.27	0.22	0.27	0.25	0.13	0.04
Unearned Revenue	0.99	-	-	1.34	2.7	2.7
Other Current Liabilities	0	0.33	0.33	0	0.05	0.09
Total Current Liabilities	6.12	5.69	53.21	5.75	6.68	4.54
Long-Term Leases	0.59	0.16	0.34	0.65	0.4	0.03
Other Long-Term Liabilities	11.46	4.09	4.1	4.09	4.4	7.19
Total Long-Term Liabilities	12.04	4.25	4.44	4.74	4.8	7.22
Total Liabilities	18.16	9.93	57.66	10.49	11.48	11.75
Common Stock	0.49	0.48	0.49	0.48	0.42	0.28
Additional Paid-in Capital	325.37	322.4	320.89	314.42	230.2	125.21
Retained Earnings	-122.58	-176.62	-157.56	-163.08	-114.85	-92.61
Total Common Shareholders' Equity	203.28	146.27	163.82	151.81	115.77	32.88
Minority Interest	-0.95	-0.92	-0.93	-0.66	0.74	-
Shareholders' Equity	202.33	145.35	162.89	151.16	116.52	32.88
Total Liabilities & Equity	220.49	155.28	220.55	161.64	128	44.63
Total Debt	0.86	0.37	51.62	0.89	0.53	0.08
Net Cash (Debt)	133.83	141.56	110.43	154.83	93.61	39.83
Net Cash Growth	-5.46%	28.19%	-28.68%	65.40%	135.05%	23.37%
Net Cash Per Share	3.20	3.47	2.72	3.97	3.29	1.94
Book Value	203.28	146.27	163.82	151.81	115.77	32.88
Book Value Per Share	4.86	3.58	4.04	3.89	4.07	1.60
Tangible Book Value	203.28	146.27	163.82	151.81	115.77	32.88
Tangible Book Value Per Share	4.86	3.58	4.04	3.89	4.07	1.60

Updated Sep 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q